At a glance
- Originator Sanofi-Synthelabo
- Class Cardiotonics; Indoles; Muscle relaxants; Sulfones; Vasodilators
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Atherosclerosis; Heart failure; Hypertension